Cargando…

Are Estrogen Receptor Genomic Aberrations Predictive of Hormone Therapy Response in Breast Cancer?

CONTEXT: Breast cancer is the most common cancer in women worldwide. Estrogen receptor (ER) positive breast cancer constitutes the majority of these cancers. Hormone therapy has significantly improved clinical outcomes for early- and late-stage hormone receptor positive breast cancer. Although most...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tabarestani, Sanaz, Motallebi, Marzieh, Akbari, Mohammad Esmaeil
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Shahid Beheshti University of Medical Sciences 2016
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5056018/ https://www.ncbi.nlm.nih.gov/pubmed/27761212 http://dx.doi.org/10.17795/ijcp-6565

Ejemplares similares

Granzyme H Serum Levels Variations with Both Reproductive Hormone Receptors, and Related Hormone Receptors in Breast Cancer Patients
por: Tahbaz-lahafi, Behnoosh, et al.
Publicado: (2014)

New Developments in Chronic Myeloid Leukemia: Implications for Therapy
por: Tabarestani, Sanaz, et al.
Publicado: (2016)

Promoter Hypermethylation of Estrogen Receptor Alpha Gene Is Correlated to Estrogen Receptor Negativity in Iranian Patients with Sporadic Breast Cancer
por: Izadi, Pantea, et al.
Publicado: (2012)

Breast cancer survivals and hormone therapy: estrogen and melatonin
por: Soares, José Maria, et al.
Publicado: (2023)

Effect of Estrogen Receptor Expression Level and Hormonal Therapy on Prognosis of Early Breast Cancer
por: Yoon, Kyung-Hwak, et al.
Publicado: (2022)

Investigating the role of endogenous estrogens, hormone replacement therapy, and blockade of estrogen receptor-α activity on breast metabolic signaling
por: Arnone, Alana A., et al.
Publicado: (2021)

Aberrant Splicing of Estrogen Receptor, HER2, and CD44 Genes in Breast Cancer
por: Inoue, Kazushi, et al.
Publicado: (2015)

Estrogen receptor splice variants as a potential source of false-positive estrogen receptor status in breast cancer diagnostics
por: Groenendijk, Floris H., et al.
Publicado: (2013)

Effecst of Patho- Biological Factors on the Survival of Recurrent Breast Cancer Cases
por: Akbari, Mohammad Esmaeil, et al.
Publicado: (2018)

Epigenetics of Estrogen Receptor Signaling: Role in Hormonal Cancer Progression and Therapy
por: Mann, Monica, et al.
Publicado: (2011)

Activity of Estrogen Receptor β Agonists in Therapy-Resistant Estrogen Receptor-Positive Breast Cancer
por: Datta, Jharna, et al.
Publicado: (2022)

Estrogen Signaling and the DNA Damage Response in Hormone Dependent Breast Cancers
por: Caldon, C. Elizabeth
Publicado: (2014)

Masculinizing hormone therapy effect on breast tissue: Changes in estrogen and androgen receptors in transgender female-to-male mastectomies
por: Chaum, Manita, et al.
Publicado: (2023)

Genome-Wide Estrogen Receptor Activity in Breast Cancer
por: Farcas, Anca M, et al.
Publicado: (2020)

Endocrinology and hormone therapy in breast cancer: New insight into estrogen receptor-α function and its implication for endocrine therapy resistance in breast cancer
por: Schiff, Rachel, et al.
Publicado: (2005)

Aberrations in translational regulation are associated with poor prognosis in hormone receptor-positive breast cancer
por: Meric-Bernstam, Funda, et al.
Publicado: (2012)

Meta-analysis of integrated ChIP-seq and transcriptome data revealed genomic regions affected by estrogen receptor alpha in breast cancer
por: Piryaei, Zeynab, et al.
Publicado: (2023)

Androgen receptor in advanced breast cancer: is it useful to predict the efficacy of anti-estrogen therapy?
por: Bronte, Giuseppe, et al.
Publicado: (2018)

Twist contributes to hormone resistance in breast cancer by down-regulating estrogen receptor alpha
por: Vesuna, Farhad, et al.
Publicado: (2011)

Estrogen receptor positive breast cancers have patient specific hormone sensitivities and rely on progesterone receptor
por: Scabia, Valentina, et al.
Publicado: (2022)

The Proliferative Response to p27 Down-Regulation in Estrogen Plus Progestin Hormonal Therapy is Lost in Breast Tumors
por: Aupperlee, Mark D., et al.
Publicado: (2018)

Hormonal therapies and venous thrombosis: Estrogen matters!
por: Morimont, Laure, et al.
Publicado: (2023)

Raptor localization predicts prognosis and tamoxifen response in estrogen receptor-positive breast cancer
por: Bostner, Josefine, et al.
Publicado: (2017)

Genome engineering for estrogen receptor mutations reveals differential responses to anti-estrogens and new prognostic gene signatures for breast cancer
por: Harrod, Alison, et al.
Publicado: (2022)

Response of Estrogen-Receptor-Positive Metastatic Breast Cancer to Olaparib in Late-Line Therapy
por: Kumeta, Toko, et al.
Publicado: (2019)

Estrogen/HER2 receptor crosstalk in breast cancer: combination therapies to improve outcomes for patients with hormone receptor-positive/HER2-positive breast cancer
por: Pegram, Mark, et al.
Publicado: (2023)

Estrogen Receptors-Mediated Apoptosis in Hormone-Dependent Cancers
por: Chimento, Adele, et al.
Publicado: (2022)

Estrogen receptor transcription and transactivation: Estrogen receptor alpha and estrogen receptor beta - regulation by selective estrogen receptor modulators and importance in breast cancer
por: S Katzenellenbogen, Benita, et al.
Publicado: (2000)

Estrogen-regulated feedback loop limits the efficacy of estrogen receptor–targeted breast cancer therapy
por: Xiao, Tengfei, et al.
Publicado: (2018)

Estrogen receptors and breast cancer.
por: Nicholson, R I, et al.
Publicado: (1981)

Who is Responsible?
por: Akbari, Mohammad Esmaeil
Publicado: (2015)

Could Perimenopausal Estrogen Prevent Breast Cancer? Exploring the Differential Effects of Estrogen-Only Versus Combined Hormone Replacement Therapy
por: Manyonda, Isaac, et al.
Publicado: (2022)

Advances in Preventive Therapy for Estrogen-Receptor-Negative Breast Cancer
por: Litzenburger, Beate C., et al.
Publicado: (2014)

Benzothiophenone Derivatives Targeting Mutant Forms of Estrogen Receptor-α in Hormone-Resistant Breast Cancers
por: Singh, Kriti, et al.
Publicado: (2018)

Neoadjuvant Hormonal Therapy is Associated with Comparable Outcomes to Neoadjuvant Chemotherapy in Post-Menopausal Women with Estrogen Receptor-Positive Breast Cancer
por: Marcus, David M., et al.
Publicado: (2013)

High estrogen receptor alpha activation confers resistance to estrogen deprivation and is required for therapeutic response to estrogen in breast cancer
por: Traphagen, Nicole A., et al.
Publicado: (2021)

Estrogen receptor-dependent genomic expression profiles in breast cancer cells in response to fatty acids
por: Alquobaili, Faizeh, et al.
Publicado: (2010)

RhoB modifies estrogen responses in breast cancer cells by influencing expression of the estrogen receptor
por: Médale-Giamarchi, Claire, et al.
Publicado: (2013)

A Closer Look at Estrogen Receptor Mutations in Breast Cancer and Their Implications for Estrogen and Antiestrogen Responses
por: Clusan, Léa, et al.
Publicado: (2021)

Placental expression of estrogen receptor beta and its hormone binding variant – comparison with estrogen receptor alpha and a role for estrogen receptors in asymmetric division and differentiation of estrogen-dependent cells
por: Bukovsky, Antonin, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_75ceqj6tnokm6gmr6asnl1hfhn